Novartis to Open, at FDA Request, New Trial of Zolgensma for Older Patients

SMA News Today’s multimedia associate, Price Wooldridge, discusses Novartis opening, at FDA request, a new trial of Zolgensma for older patients.

Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/